Host Microenvironment in Breast Cancer Development: Inflammatory Cells, Cytokines and Chemokines in Breast Cancer Progression: Reciprocal Tumor-microenvironment Interactions

Overview

Journal Breast Cancer Res

Specialty Oncology

Date 2003 Feb 1

PMID 12559043

Citations 120

Authors

A Ben-Baruch

Affiliations

Soon will be listed here.

Abstract

A comprehensive overview of breast cancer development and progression suggests that the process is influenced by intrinsic properties of the tumor cells, as well as by microenvironmental factors. Indeed, in breast carcinoma, an intensive interplay exists between the tumor cells on one hand, and inflammatory cells/cytokines/chemokines on the other. The purpose of the present review is to outline the reciprocal interactions that exist between these different elements, and to shed light on their potential involvement in breast cancer development and progression.

Citing Articles

Cold-Inducible RNA Binding Protein Impedes Breast Tumor Growth in the PyMT Murine Model for Breast Cancer.

Lujan D, Ochoa J, Beswick E, Howard T, Hathaway H, Perrone-Bizzozero N Biomedicines. 2024; 12(2).

PMID: 38397942 PMC: 10886683. DOI: 10.3390/biomedicines12020340.

Critical Roles of SRC-3 in the Development and Progression of Breast Cancer, Rendering It a Prospective Clinical Target.

Varisli L, Dancik G, Tolan V, Vlahopoulos S Cancers (Basel). 2023; 15(21).

PMID: 37958417 PMC: 10648290. DOI: 10.3390/cancers15215242.

Cell- and subcellular organelle-targeting nanoparticle-mediated breast cancer therapy.

Wei X, Yang M Front Pharmacol. 2023; 14:1180794.

PMID: 37089933 PMC: 10117787. DOI: 10.3389/fphar.2023.1180794.

The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies.

Melaiu O, Vanni G, Portarena I, Pistolese C, Anemona L, Pomella S Int J Mol Sci. 2023; 24(4).

PMID: 36834641 PMC: 9964596. DOI: 10.3390/ijms24043226.

Environmental exposure and the role of AhR in the tumor microenvironment of breast cancer.

Sweeney C, Lazennec G, Vogel C Front Pharmacol. 2023; 13:1095289.

PMID: 36588678 PMC: 9797527. DOI: 10.3389/fphar.2022.1095289.

References

Kurebayashi J . Regulation of interleukin-6 secretion from breast cancer cells and its clinical implications. Breast Cancer. 2000; 7(2):124-9. DOI: 10.1007/BF02967443. View

Ueno T, Toi M, Saji H, Muta M, Bando H, Kuroi K . Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res. 2000; 6(8):3282-9. View

Balkwill F, Mantovani A . Inflammation and cancer: back to Virchow?. Lancet. 2001; 357(9255):539-45. DOI: 10.1016/S0140-6736(00)04046-0. View

Niwa Y, Akamatsu H, Niwa H, Sumi H, Ozaki Y, Abe A . Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin Cancer Res. 2001; 7(2):285-9. View

Muller A, Homey B, Soto H, Ge N, CATRON D, Buchanan M . Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001; 410(6824):50-6. DOI: 10.1038/35065016. View

Mira E, Lacalle R, Gonzalez M, Abad J, Bernad A, Martinez-A C . A role for chemokine receptor transactivation in growth factor signaling. EMBO Rep. 2001; 2(2):151-6. PMC: 1083823. DOI: 10.1093/embo-reports/kve027. View

Saji H, Koike M, Yamori T, Saji S, Seiki M, Matsushima K . Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma. Cancer. 2001; 92(5):1085-91. DOI: 10.1002/1097-0142(20010901)92:5<1085::aid-cncr1424>3.0.co;2-k. View

Crowther M, Brown N, Bishop E, Lewis C . Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J Leukoc Biol. 2001; 70(4):478-90. View

Miller L, Kurtzman S, Wang Y, Anderson K, LINDQUIST R, Kreutzer D . Expression of interleukin-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue. Anticancer Res. 1998; 18(1A):77-81. View

10.

Stewart T, Heppner G . Immunological enhancement of breast cancer. Parasitology. 1997; 115 Suppl:S141-53. DOI: 10.1017/s0031182097001832. View

11.

Leek R, Landers R, Fox S, Ng F, Harris A, Lewis C . Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma. Br J Cancer. 1998; 77(12):2246-51. PMC: 2150409. DOI: 10.1038/bjc.1998.373. View

12.

Hadden J . The immunology and immunotherapy of breast cancer: an update. Int J Immunopharmacol. 1999; 21(2):79-101. DOI: 10.1016/s0192-0561(98)00077-0. View

13.

Goede V, Brogelli L, Ziche M, Augustin H . Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int J Cancer. 1999; 82(5):765-70. DOI: 10.1002/(sici)1097-0215(19990827)82:5<765::aid-ijc23>3.0.co;2-f. View

14.

Luboshits G, Shina S, Kaplan O, Engelberg S, Nass D, Chaitchik S . Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. Cancer Res. 1999; 59(18):4681-7. View

15.

Klier C, Nelson E, Cohen C, Horuk R, Schlondorff D, Nelson P . Chemokine-Induced secretion of gelatinase B in primary human monocytes. Biol Chem. 2001; 382(9):1405-10. DOI: 10.1515/BC.2001.173. View

16.

Azenshtein E, Luboshits G, Shina S, Neumark E, Shahbazian D, Weil M . The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. Cancer Res. 2002; 62(4):1093-102. View

17.

Balkwill F . Tumor necrosis factor or tumor promoting factor?. Cytokine Growth Factor Rev. 2002; 13(2):135-41. DOI: 10.1016/s1359-6101(01)00020-x. View

18.

Dorsey R, Kundu N, Yang Q, Tannenbaum C, Sun H, Hamilton T . Immunotherapy with interleukin-10 depends on the CXC chemokines inducible protein-10 and monokine induced by IFN-gamma. Cancer Res. 2002; 62(9):2606-10. View

19.

van Netten J, Ashmed B, Cavers D, Fletcher C, Thornton I, Antonsen B . 'Macrophages' and their putative significance in human breast cancer. Br J Cancer. 1992; 66(1):220-1. PMC: 1977886. DOI: 10.1038/bjc.1992.245. View

20.

Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L . The origin and function of tumor-associated macrophages. Immunol Today. 1992; 13(7):265-70. DOI: 10.1016/0167-5699(92)90008-U. View